RUNX3 and neoplasm: Its tumor suppressive activity was first identified in gastric epithelial cells of RUNX3 knockdown mice, where absence of RUNX3 resulted in increased proliferative activity, suppressed apoptosis and decreased sensitivity to transforming growth factor beta (TGF-β) [85].